Delivery Order SPE2DB22D3501-SPE2DB24FTU92
Award Date 12/11/23
Potential Completion Date 1/3/24
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company. The contract, valued at $10,578.39, is for the delivery of 4564002715 - LORBRENA 100 MG TABLET 30S, a specialty pharmaceutical product. The award has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LORBRENA 100 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $21,156.78 and a completion date of April 1, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LORBRENA 100 MG TABLET 30S. The contract has an award value of $21,156.78 and a completion date of February 20, 2024. It is a Delivery Order contract with a Firm Fixed Price pricing type, awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,344.30, is for the delivery of Lorbrena 100 mg tablets over a period ending on March 19, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $10,965.33, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product LORBRENA 100 MG TABLET 30S. Amerisourcebergen, a major pharmaceutical distributor, has significant experience supplying medical products and prescription drugs to the U.S. government, particularly the Department of Defense (DoD) and Veterans Affairs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $10,965.33, is for the delivery of 4,564,294,649 tablets of the drug Lorbrena (100 mg) to the government. Amerisourcebergen Drug Corp, through its Corporate Office Division, holds a single-award Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lorbrena 100mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $23,248.70, is scheduled for completion by August 11, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania location. The award was made on a competitive basis with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $23,248.72 on September 5, 2025, for the supply of Lorbrena 100 mg tablets (30-count units). This firm fixed-price, competitively awarded contract carries an ultimate completion date of September 26, 2025, and involves performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award contains no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $24,500.56 to AmerisourceBergen Drug Corp for Lorbrena 100mg tablets (30-count) on November 17, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Lorbrena 100 mg tablets (30-count) valued at $11,624.35. This firm fixed-price delivery order, awarded on August 21, 2025, is scheduled for completion by September 12, 2025, with performance at the vendor's Conshohocken facility. The award represents a non-competitive, non-set-aside transaction, indicating it was...